End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.71 PLN | 0.00% | -0.58% | +25.74% |
Valuation
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|
Capitalization 1 | 11.54 | 6.348 | 2.806 | 7.55 | 9.376 |
Enterprise Value (EV) 1 | 11.98 | 6.997 | 3.149 | 5.863 | 7.488 |
P/E ratio | -37.1 x | -4.38 x | -23.8 x | 34.7 x | 32.9 x |
Yield | - | - | - | - | - |
Capitalization / Revenue | 2.16 x | 1.02 x | 0.56 x | 1.51 x | 1.84 x |
EV / Revenue | 2.24 x | 1.12 x | 0.63 x | 1.17 x | 1.47 x |
EV / EBITDA | -264 x | -8.52 x | 15.4 x | 9.17 x | 14.6 x |
EV / FCF | -64.6 x | -4.89 x | 10.8 x | 16.9 x | 94.7 x |
FCF Yield | -1.55% | -20.5% | 9.28% | 5.93% | 1.06% |
Price to Book | 11.6 x | 6.67 x | 3.36 x | 3.42 x | 2.98 x |
Nbr of stocks (in thousands) | 5,800 | 6,682 | 6,682 | 6,682 | 8,682 |
Reference price 2 | 1.990 | 0.9500 | 0.4200 | 1.130 | 1.080 |
Announcement Date | 18-05-31 | 19-04-08 | 20-06-03 | 21-05-31 | 22-06-30 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|
Net sales 1 | 5.354 | 6.233 | 4.995 | 5.011 | 5.098 |
EBITDA 1 | -0.0454 | -0.8211 | 0.2039 | 0.6393 | 0.5144 |
EBIT 1 | -0.2797 | -1.302 | -0.3079 | 0.1936 | 0.2174 |
Operating Margin | -5.22% | -20.89% | -6.16% | 3.86% | 4.26% |
Earnings before Tax (EBT) 1 | -0.2905 | -1.406 | -0.1179 | 0.2825 | 0.1942 |
Net income 1 | -0.3115 | -1.449 | -0.1179 | 0.2825 | 0.2852 |
Net margin | -5.82% | -23.26% | -2.36% | 5.64% | 5.59% |
EPS 2 | -0.0537 | -0.2169 | -0.0176 | 0.0325 | 0.0328 |
Free Cash Flow 1 | -0.1853 | -1.431 | 0.2921 | 0.3479 | 0.079 |
FCF margin | -3.46% | -22.97% | 5.85% | 6.94% | 1.55% |
FCF Conversion (EBITDA) | - | - | 143.23% | 54.41% | 15.37% |
FCF Conversion (Net income) | - | - | - | 123.14% | 27.72% |
Dividend per Share | - | - | - | - | - |
Announcement Date | 18-05-31 | 19-04-08 | 20-06-03 | 21-05-31 | 22-06-30 |
Balance Sheet Analysis
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|
Net Debt 1 | 0.44 | 0.65 | 0.34 | - | - |
Net Cash position 1 | - | - | - | 1.69 | 1.89 |
Leverage (Debt/EBITDA) | -9.604 x | -0.7909 x | 1.68 x | - | - |
Free Cash Flow 1 | -0.19 | -1.43 | 0.29 | 0.35 | 0.08 |
ROE (net income / shareholders' equity) | -27.2% | -149% | -13.2% | 15.3% | 9.48% |
ROA (Net income/ Total Assets) | -7.3% | -28.7% | -5.61% | 2.86% | 2.85% |
Assets 1 | 4.265 | 5.048 | 2.103 | 9.888 | 9.991 |
Book Value Per Share 2 | 0.1700 | 0.1400 | 0.1200 | 0.3300 | 0.3600 |
Cash Flow per Share 2 | 0 | 0 | 0.0400 | 0.2500 | 0.2300 |
Capex 1 | 0.46 | 1.24 | 0.02 | 0.23 | - |
Capex / Sales | 8.55% | 19.95% | 0.39% | 4.64% | - |
Announcement Date | 18-05-31 | 19-04-08 | 20-06-03 | 21-05-31 | 22-06-30 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+25.74% | 4.53M | |
-54.53% | 1.72B | |
-7.87% | 394M | |
+8.04% | 353M | |
-77.56% | 111M | |
-33.96% | 84.88M |
- Stock Market
- Equities
- TMP Stock
- Financials Telemedycyna Polska S.A.